THE FUNCTION OF THE PITUITARY‐THYROIDAL AXIS IN ACROMEGALIC PATIENTS V. PATIENTS WITH HYPERPROLACTINAEMIA AND A PITUITARY TUMOUR
- 1 December 1980
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 13 (6) , 577-585
- https://doi.org/10.1111/j.1365-2265.1980.tb03426.x
Abstract
SUMMARY: The function of the pituitary‐thyroidal axis was examined in fifty‐three of sixty‐two patients with hyperprolactinaemia and a pituitary tumour and in forty of forty‐four acromegalic patients, in whom one or more indices of the pituitary‐thyroid function were determined before treatment. In the patients with hyperprolactinaemia and a pituitary tumour, sellar + extrasellar tissue (EST) size showed a significant negative correlation with the response of TSH to TRH (ΔTSH) as well as with the circulating T4 and T3 levels. These correlations were not present in the acromegalic patients. In the prolactinoma group a sharp decrease in mean serum T4 and T3 levels was found at sellar + EST sizes exceeding 3 cm2. In twenty‐three patients with a sellar + EST size of 3 cm2 or more, thirteen (57%) showed a T4 level of less than 6 μg/dl against none of twenty‐eight patients with a sellar + EST size of less than 3 cm2. For T3, using a limit of 120 ng/dl, the corresponding numbers were eight out of thirteen (62%) and none of ten patients respectively. A positive correlation was observed between ΔTSH and the T3 levels but not between ΔTSH and T4, while in the acromegalic patients there was no correlation between TSH reserve and T3 or T4. In the patients with hyperprolactinaemia and a pituitary tumour positive correlations between basal TSH and ΔTSH as well as between T4 and T3 levels were observed. These correlations were not found in the acromegalic patients.In conclusion: (1) Thyroid function appears to be independent of pituitary tumour size in patients with acromegaly but not in patients with hyperprolactinaemia and a pituitary tumour. (2) In acromegalic patients the high incidence of an impaired TSH response (without hypothyroidism and independent of tumour size) may be caused by suppression of TSH secretion rather than by destruction of thyrotrophic cells.This publication has 12 references indexed in Scilit:
- THE IMPORTANCE OF PITUITARY TUMOUR SIZE IN PATIENTS WITH HYPERPROLACTINAEMIA IN RELATION TO HORMONAL VARIABLES AND EXTRASELLAR EXTENSION OF TUMOURClinical Endocrinology, 1980
- The Effect of Thyroidectomy, Hypophysectomy, and Hormone Replacement on the Formation of Triiodothyronine from Thyroxine in Rat Liver and Kidney*Endocrinology, 1978
- SERUM GROWTH HORMONE AND ULTRASTRUCTURAL STUDIES OF ADENOHYPOPHYSIAL TISSUE IN BROMOCRIPTINE TREATED ACROMEGALIC PATIENTSClinical Endocrinology, 1978
- THE SECRETION OF THYROTROPHIN WITH IMPAIRED BIOLOGICAL ACTIVITY IN PATIENTS WITH HYPOTHALAMIC–PITUITARY DISEASEClinical Endocrinology, 1978
- RESPONSE TO THYROTROPHIN‐RELEASING HORMONE AND TRIIODOTHYRONINE SUPPRESSIBILITY IN EUTHYROID MULTINODULAR GOITREClinical Endocrinology, 1977
- TRIIODOTHYRONINE RESPONSE TO THYROTROPHIN RELEASING HORMONE IN PATIENTS WITH HYPOTHALAMIC-PITUITARY DISORDERSClinical Endocrinology, 1975
- Inhibition of Thyrotropin-Releasing Hormone-Mediated Secretion of Thyrotropin by Human Growth HormoneJournal of Clinical Endocrinology & Metabolism, 1973
- THE THYROTROPHIN-RELEASING HORMONE TEST IN DISEASES OF THE PITUITARY AND HYPOTHALAMUSThe Lancet, 1972
- THE THYROID GLAND IN 166 CASES OF ACROMEGALYJournal of Clinical Endocrinology & Metabolism, 1941
- STUDIES IN ACROMEGALY III. THE ANAMNESIS AND SYMPTOMATOLOGY IN ONE HUNDRED CASESEndocrinology, 1926